Trial intelligence / Profile preview

Purified fish oils (MaxEPA) for glucose regulation in congenital hyperinsulinism of infancy

2011-003633-33Phase 2Completed

Sponsor
Manchester University NHS Foundation Trust
Start
Sep 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of eicosapentaenoic acid + docosahexaenoic acid in congenital hyperinsulinism (HI), sponsored by Manchester University NHS Foundation Trust. Started Sep 2011; status: completed.

02

Drugs

eicosapentaenoic acid + docosahexaenoic acid
03

Conditions

congenital hyperinsulinism (HI)

Beyond the preview

Go deeper on 2011-003633-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-003633-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call